Tat-CIAPIN1 Prevents Pancreatic β-Cell Death in hIAPP-Induced RINm5F Cells and T2DM Animal Model
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241310478 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Hyeon Ji Yeo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science and Research, Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Republic of Korea. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Islets of Langerhans, Insulin-Secreting Cells. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education., Basic Science Research Program.
Abstract (Originalsprache)
It is well known that the cytokine-induced apoptosis inhibitor 1 (CIAPIN1) protein plays an important role in biological progresses as an anti-apoptotic protein. Human islet amyloid peptide (hIAPP), known as amylin, is caused to pancreatic β-cell death in type 2 diabetes mellitus (T2DM). However, the function of CIAPIN1 protein on T2DM is not yet well studied. Therefore, we investigated the effects of CIAPIN1 protein on a hIAPP-induced RINm5F cell and T2DM animal model induced by a high-fat diet (HFD) and streptozotocin (STZ). The Tat-CIAPIN1 protein reduced the activation of mitogen-activated protein kinase (MAPK) and regulated the apoptosis-related protein expression levels including COX-2, iNOS, Bcl-2, Bax, and Caspase-3 in hIAPP-induced RINm5F cells. In a T2DM mice model, the Tat-CIAPIN1 protein ameliorated the pathological changes of pancreatic β-cells and reduced the fasting blood glucose, body weight and hemoglobin Alc (HbAlc) levels. In conclusion, the Tat-CIAPIN1 protein showed protective effects against T2DM by protection of β-cells via inhibition of hIAPP toxicity and by regulation of a MAPK signal pathway, suggesting CIAPIN1 protein can be a therapeutic protein drug candidate by beneficial regulation of T2DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Science and Research, Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Republic of Korea.
- Department of Anatomy, College of Dentistry, Gangneung-Wonju National University, Gangneung 25457, Republic of Korea.
Förderung
- Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education.
- Basic Science Research Program
Zitieren
APA
Yeo, H. J., Shin, M. J., Yoo, K. Y., Jung, B. H., Eum, W. S., & Choi, S. Y. (2023). Tat-CIAPIN1 Prevents Pancreatic β-Cell Death in hIAPP-Induced RINm5F Cells and T2DM Animal Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241310478
Vancouver
Yeo HJ, Shin MJ, Yoo KY, Jung BH, Eum WS, Choi SY. Tat-CIAPIN1 Prevents Pancreatic β-Cell Death in hIAPP-Induced RINm5F Cells and T2DM Animal Model. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241310478
BibTeX
@article{Yeo2023,
author = {Yeo, Hyeon Ji and Shin, Min Jea and Yoo, Ki-Yeon and Jung, Bo Hyun and Eum, Won Sik and Choi, Soo Young},
title = {Tat-CIAPIN1 Prevents Pancreatic β-Cell Death in hIAPP-Induced RINm5F Cells and T2DM Animal Model},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241310478}
}
EUVIMED